Medinice (WAR:ICE) Current Accrued Expense : zł0.00 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Medinice Current Accrued Expense?

Medinice's Current Accrued Expense for the quarter that ended in Mar. 2024 was zł0.00 Mil.

Medinice Current Accrued Expense Historical Data

The historical data trend for Medinice's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medinice Current Accrued Expense Chart

Medinice Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

Medinice Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Medinice Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Medinice Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Medinice's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Medinice (WAR:ICE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medinice SA (WAR:ICE) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Karola Olszewskiego 6, Kielce, POL, 25-663

Website

http://www.medinice.pl

Medinice SA is a Polish company operating in the MedTech industry. The company is engaged in creating, developing and commercializing solutions in the field of medicine, in particular, cardiology and cardio surgery. Its portfolio includes close around 12 projects including CathAIO, an electrode with universal diagnostic, electrophysiological, haemodinamic and biohemic functions and can be used for RF ablation; cryoapplicator, for minimally invasive cardiosurgical cryoablation; Med-iConsole allows to reduce the need to use multiple computer devices during electrophysiological treatment; Minimax and Pacepress.